뉴스

• KM Pharmaceutical Surges Despite Delisting; SK Biopharm Falls on FDA Hold [K-Bio Pulse] Korean pharmaceutical and biotech stocks showed mixed performances on Sept. 11, with KM Pharmaceutical and BL Pharmtech both hitting their daily upper price lim www.edaily.co.kr · 2026.09.14